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Abstract
 
Autoimmune regulator (AIRE) gene mutation is responsible for the development of autoimmune-
polyendocrinopathy-candidiasis ectodermal dystrophy, an organ-specific autoimmune disease
with monogenic autosomal recessive inheritance. AIRE is predominantly expressed in medullary
epithelial cells of the thymus and is considered to play important roles in the establishment of
self-tolerance. AIRE contains two plant homeodomain (PHD) domains, and the novel role of
PHD as an E3 ubiquitin (Ub) ligase has just emerged. Here we show that the first PHD
(PHD1) of AIRE mediates E3 ligase activity. The significance of this finding was underscored
by the fact that disease-causing missense mutations in the PHD1 (C311Y and P326Q) abolished
its E3 ligase activity. These results add a novel enzymatic function for AIRE and suggest an
indispensable role of the Ub proteasome pathway in the establishment of self-tolerance, in
which AIRE is involved.
Key words: APECED • self-tolerance • transcriptional regulator • ubiquitylation • PHD domain
 
Introduction
 
Autoimmune disease is a pathological condition in which
the immune system turns on itself and causes serious
damage to the organism’s tissues by as yet unknown
mechanisms (1). Although a propensity to appear in families
is one of the common features of autoimmune diseases,
only a few genes relevant to the pathogenetic processes
that underlie the development of autoimmune diseases
per se are actually known (2). Because autoimmune regu-
lator (AIRE) gene mutation is responsible for the devel-
opment of autoimmune-polyendocrinopathy-candidiasis
ectodermal dystrophy (APECED: OMIM 240300; references
3–6), an organ-specific autoimmune disease with monogenic
autosomal recessive inheritance, understanding the rela-
tionship between AIRE gene malfunction and the break-
down of self-tolerance promises to help unravel the
pathogenesis of not only APECED, but also other types
of autoimmune disease. Supporting this notion, AIRE is
predominantly expressed in medullary epithelial cells of
the thymus (7, 8).
The ubiquitin (Ub) proteasome pathway plays an essential
role in diverse cell functions such as cell cycle progression,
signal transduction, cell differentiation, DNA repair, and
apoptosis (9, 10). The system responsible for Ub attach-
ment consists of several components that act in concert. A
Ub-activating enzyme (E1) catalyzes the formation of a
thioester bond between itself and Ub, and then transfers
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the activated Ub to a Ub-conjugating enzyme (E2). E3 li-
gase interacts with both E2 and the substrate, and facilitates
polyubiquitylation of the substrate (9, 10). The plant ho-
meodomain (PHD) is found in many proteins involved in
chromatin-mediated transcriptional regulation (11). It is
noteworthy that PHD resembles the RING finger, which
functions as an E3 ligase (12) in both sequence and struc-
ture (13, 14). The RING finger and PHD contain a motif
defined by an octet of cysteines and histidines with similar
spacing that coordinates two zinc ions (15). Although the
exact definition of PHD requires further study (16), recent
studies have demonstrated that a subset of PHD-containing
proteins such as Kaposi’s sarcoma-associated herpes virus
proteins (17, 18) and MAP kinase/ERK kinase (MEKK1)
mediates E3 ligase activity (19).
The AIRE gene encodes a predicted 58-kD protein car-
rying two PHDs together with a homogeneously staining
region and SAND domains (3, 4). Although the homoge-
neously staining region and SAND domains have been sug-
gested to function in homodimerization and DNA binding,
respectively (20, 21), the exact function of PHDs in the
AIRE remains elusive. Significantly, Finnish mutation
R257X and the 13-bp deletion in exon 8 are the most fre-
quent mutations found, both producing truncated AIRE
proteins lacking both PHD1 and PHD2, or lacking PHD2
with a disrupted PHD1, respectively (5, 6). Recent observa-
tions demonstrating the E3 ligase activity of PHD-contain-
ing proteins have prompted us to test whether AIRE may
act as an E3 ligase. Here we show that the PHD1 of AIRE
mediates E3 ligase activity. Of note, we further show that
disease-causing missense mutations in the PHD1 (C311Y
and P326Q) abolished its E3 ligase activity, suggesting an
indispensable role of the Ub proteasome pathway in the es-
tablishment of self-tolerance, in which AIRE is involved.
 
Materials and Methods
 
Construction of the Expression Plasmids and Mutagenesis for
AIRE.
 
Human AIRE cDNA was amplified by PCR from Mar-
athon-Ready human thymus cDNA (CLONTECH Laborato-
ries, Inc.). In brief, AIRE cDNA was first amplified with adaptor
primers according to the manufacturer’s instructions, and then
nested PCR was performed with AIRE-specific primers to which
EcoRI and SalI restriction sites were added at the 5
 
  
 
and 3
 
  
 
ends,
respectively. The following primers were used. AIRE-U1: CG-
GAATTCATGGCGACGGACGCGGCGCTAC; AIRE-D1:
ACGCGTCGACTCAGGAGGGGAAGGGGGCCG. The re-
sulting fragment containing the human AIRE open reading frame
was ligated into the cloning site downstream of the FLAG-tag in
the pCR3 vector (Invitrogen) or His
 
6
 
-tag in pFastBac HTa (In-
vitrogen). Site-directed mutagenesis for the generation of C299A,
C311Y, P326Q, C434A, and C299A/C434A mutants was per-
formed using human AIRE cDNA cloned into pBluescript II
SK
 
  
 
(Stratagene) as a template with a Quick Change (Stratagene).
The sequence of each constructed vector was confirmed by the
dideoxy chain termination method with automated sequencing
(Applied Biosystems).
 
Production of Recombinant Proteins in Bacteria.
 
The plasmids
containing various human E2s (i.e., Ubc2A, Ubc2B, Ubc3,
Ubc4, UbcH5A, UbcH5B, UbcH5C, UbcH6, UbcH7, and
UbcH8) in pT7-7 or pET30a (Novagen) were constructed as
previously described (22). These His
 
6
 
-tagged proteins were ex-
pressed in 
 
Escherichia coli
 
 strain BL21(DE3)pLysS (Novagen) cul-
tured in the presence of 0.1 mM isopropyl-
 
 
 
-D-thiogalactopyra-
noside. The recombinant E2 proteins were purified with the use
of ProBand resin (Invitrogen) as previously described (22).
 
Baculovirus Expression System.
 
The plasmid pFastBac HTa
containing the relevant cDNA was subjected to recombination
with the baculoviral genome in HB10BAC, and the resulting re-
combinant viral genome was introduced into Sf21 cells by transfec-
tion to generate recombinant baculovirus. The infected Sf21 cells
were lysed and the recombinant proteins were purified by the pro-
tocol described for bacterially expressed His
 
6
 
-tagged proteins (22).
 
In Vitro Ubiquitylation Assay.
 
The PHD1 (amino acids 280–
374) and PHD2 (amino acids 415–509) domains were PCR am-
plified and fused to the carboxyl terminus of the pGEX-4T-1 vec-
tor (Amersham Biosciences). The constructs were introduced into
 
E. coli
 
 strain BL21-CodonPlus(DE3)-RP (Stratagene) and expres-
sion of glutathione 
 
S
 
-transferase (GST) fusion proteins was in-
duced by 0.1 mM isopropyl-
 
 
 
-D-thiogalactopyranoside. Bacterial
pellets were sonicated in PBS containing protease inhibitors, 1%
Triton X-100, and 0.1% sarcosyl. After being cleared by centrifu-
gation, the bacterial lysates were incubated with glutathione-
Sepharose 4B beads (Amersham Biosciences) for purification. The
in vitro ubiquitylation assays were performed as previously de-
scribed (22). In brief, reaction mixtures (20 
 
 
 
l) containing either 1
 
 
 
g of the full-sized recombinant AIRE or 5 
 
 
 
g GST-PHD fusion
proteins, together with 0.1 
 
 
 
g recombinant rabbit E1 (Boston
Biomedica), 1 
 
 
 
l crude 
 
E. coli
 
 lysate containing various E2s, 0.5 U
phosphocreatine kinase, 1 
 
 
 
g Ub (Sigma-Aldrich), 25 mM Tris-
HCl, pH 7.5, 120 mM NaCl, 2 mM ATP, 1 mM MgCl
 
2
 
, 0.3 mM
dithiothreitol, and 1mM creatine phosphate were incubated for
2 h at 30
 
 
 
C. In some assays, rabbit reticulocyte lysate (Promega)
was used as a source of E1 and E2. The reaction was terminated by
the addition of SDS sample buffer containing 4% 2-ME and heat-
ing at 95
 
 
 
C for 5 min. Samples were resolved by SDS-PAGE on a
6% gel and then subjected to immunoblot analysis with a mouse
monoclonal antibody against Ub (clone 1B3; MBL International
Corporation) and a horseradish peroxidase–conjugated rabbit
polyclonal antibody against mouse immunoglobulin (Southern
Biotechnology Associates, Inc.). Signals were detected with ECL
(Amersham Biosciences).
 
Reporter Gene Assay.
 
Gal4-binding assays were performed
with a CheckMate Mammalian Two-Hybrid System (Promega)
according to the manufacturer’s instructions. In brief, human
AIRE cDNAs were subcloned into the pBIND vector containing
the 
 
Renilla
 
 luciferase gene driven by the SV40 early enhancer/pro-
moter. 0.2 
 
 
 
g pBIND-AIRE vectors were transfected into mouse
epithelial cell line of thymic medulla origin (mTEC; 1C6; pro-
vided by M. Kasai, National Institute of Infectious Diseases, To-
kyo, Japan; reference 23) with 0.2 
 
 
 
g of the pG5
 
luc
 
 vector using
LIPOFECTAMINE 2000 Reagent (GIBCO BRL). After 48 h,
the cells were harvested and activities were determined with the
dual luciferase reporter gene assay system (Promega).
 
RT-PCR.
 
RNAs were extracted from mouse organs with
TRIzol (Invitrogen) and treated with DNase to eliminate any
contaminating DNA. After phenol/chloroform extraction and
ethanol precipitation, 5 
 
 
 
g total RNA was subjected to oligo(dT)-
primed reverse transcription with a cDNA cycle kit (Invitrogen).
The primer pairs used for PCR were 5
 
 
 
-CAAGGAATTGAAT-
GACCTGG-3
 
  
 
and 5
 
 
 
-GAGTCCATTCCCGAGCTATT-3
 
  
 
for
Ubc4 and 5
 
 
 
-TGGAATCCTGTGGCATCCATGAAAC-3
 
  
 
and 
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5
 
 
 
-TAAAACGCAGCTCAGTAACAGTCCG-3
 
  
 
for 
 
 
 
-actin.
PCR was performed in a final volume of 30 
 
 
 
l with 1.5 U ExTaq
DNA polymerase (Takara Biomedicals) and 250 nM of each
primer. Cycling conditions were a single denaturing step at 94
 
 
 
C
for 10 min followed by 30 cycles of 94
 
 
 
C for 30 s, 60
 
 
 
C for 30 s,
and 72
 
 
 
C for 1.5 min, followed by a final extension step of 72
 
 
 
C
for 10 min.
 
Online Supplemental Material.
 
Fig. S1 shows Ubc4 expression
in the thymus, and Fig. S2 shows that AIRE mediates ubiquityla-
tion with UbcH5B. These figures are available at http://www.
jem.org/cgi/content/full/jem.20031291/DC1.
 
Results and Discussion
 
PHD1 of AIRE Mediates E3 Ligase Activity.
 
When aligned
with other PHDs showing E3 ligase activity, both PHD1
and PHD2 of AIRE apparently demonstrated homology
with the PHDs from those proteins (Fig. 1 A). To deter-
mine whether the PHD1 and/or PHD2 of AIRE have E3
ligase activity, we performed in vitro ubiquitylation assays.
PHD1 and PHD2 were fused to the carboxyl terminus of
GST and the purified fusion proteins were subjected to the
assay using rabbit reticulocyte lysate as a source of E1 and
E2. Polyubiquitylated proteins were observed from the
GST-PHD1 fusion protein, whereas GST alone and the
GST-PHD2 fusion protein did not have this form, suggest-
ing that the PHD1 of AIRE mediates E3 ligase activity
(Fig. 1 B). E3 ligase activity mediated through PHD1 was
also demonstrated by the assay using recombinant E1 and
E2 (Ubc4, see below), and this activity was incubation de-
pendent (Fig. 1 C).
To further confirm the E3 ligase activity of AIRE, the
recombinant full-sized AIRE protein was expressed in Sf21
cells using a baculovirus expression system (Fig. 1 D). Be-
cause most E3s exhibit specificity for a relatively narrow
range of E2 enzymes, we simultaneously examined the
preference of the AIRE proteins for eight different human
E2 enzymes in the presence of E1. The wild-type full-sized
recombinant AIRE exhibited polyubiquitylated proteins
when Ubc4 was present as E2 in the reaction (Fig. 1 E).
Consistent with this functional association, Ubc4 was
abundantly expressed in the thymus, as is the case with
AIRE (see Fig. S1, available at http://www.jem.org/cgi/
Figure 1. AIRE mediates E3 ligase activity through
PHD1. (A) The PHD1 and PHD2 domains of AIRE
showed homology with the PHDs from other proteins
showing E3 ligase activity. *, the position of disease-
causing mutations (C311Y and P326Q) used in the
study. (B) The GST-PHD1, but not GST-PHD2, fusion
protein exhibited polyubiquitylated proteins when rabbit
reticulocyte lysate was used for in vitro ubiquitylation
assays (top). SDS-PAGE of GST-fusion proteins used
in the assay (10% input) is shown on the bottom. (C) Re-
combinant E1 and E2 (Ubc4) were used for in vitro
ubiquitylation assays (top). The ubiquitylation reactions
were subjected to immunoblot analysis with antibodies
against GST (bottom). E3 ligase activity mediated
through PHD1 is incubation dependent. *, nonspecific
bands. (D) The full-sized recombinant AIRE protein
was successfully and homogeneously expressed in Sf21
cells using a baculovirus expression system. The purified
recombinant AIRE protein was subjected to immuno-
blot analysis with an antibody against His6-tag. (E) Ubc4
E2 preference by the full-sized recombinant AIRE in
in vitro ubiquitylation assays (top). CHIP, a U-box–
type E3 ligase, is included to verify the specificity and
biological activities of E2s (middle; reference 22). Equal
amount of E2s were used in the reaction (bottom). (F)
Specificity of E3 ligase activity mediated by the full-
sized recombinant AIRE in in vitro ubiquitylation assays. 
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content/full/jem.20031291/DC1). This reaction was de-
pendent on the incubation and the presence of AIRE (Fig.
1 F), confirming the specificity of the E3 ligase activity.
Further examination has revealed that AIRE also mediates
ubiquitylation with UbcH5B, which is structurally very
close to Ubc4 (see Fig. S2, available at http://www.jem.
org/cgi/content/full/jem.20031291/DC1).
The indispensability of PHD1 for E3 ligase activity was
demonstrated with PHD mutants in which the first cys-
teines were mutated to alanines in either PHD1 (C299A),
PHD2 (C434A), or both PHDs (C299A/C434A) of the
full-sized recombinant AIRE (Fig. 2 A). Corresponding
amino acid substitution in PHD of MEKK1 has demon-
strated the significance of this cysteine for its E3 ligase ac-
tivity (19). Although the wild-type and the PHD2 mutant
(C434A) mediated polyubiquitylation, the PHD1 mutant
(C299A) and the PHD1/PHD2 double mutant (C299A/
C434A) showed no obvious polyubiquitylation (Fig. 2 B).
Together with the data obtained from GST-PHD fusion
proteins, these results indicate that AIRE mediates E3 ligase
activity primarily through PHD1. Although we cannot
completely exclude the possibility that PHD2 is involved
in the full enzymatic activity, the absence of the tryptophan
residue usually located between cysteines 6 and 7 of ligase-
type PHDs might be consistent with the lack of E3 ligase
activity from PHD2 (Fig. 1 A; reference 18).
Having identified that PHD1 of AIRE functions as an
E3 ligase, we addressed whether the loss of this function
would have any relevance to the development of
APECED. Our approach was to introduce missense muta-
tions (Figs. 1 A and 2 A, C311Y and P326Q) into the
PHD1 of the full-sized recombinant AIRE, both of which
are found in patients with APECED (6, 24). Both of the
disease-causing mutants showed dramatically reduced E3 li-
gase activity in in vitro ubiquitylation assays (Fig. 2 C),
strongly suggesting that loss of E3 ligase activity has rele-
vance to the disease process of APECED.
 
Essential Role for PHD2 in Transcriptional Activation.
 
It
has been previously demonstrated that AIRE has transcrip-
tion-activating properties when fused to a heterologous
DNA-binding domain (20, 24), and many PHD-disrupting
mutations result in decreased transcriptional activity. We
investigated whether the loss of E3 ligase activity resulting
from the disease-causing mutations C311Y and P326Q is
associated with alterations in the transcription-activating
properties assessed with a series of Gal4-binding assays. In
light of the fact that AIRE expression is most prominent in
the thymic medulla (7, 8), we used mouse mTEC (1C6;
reference 23), which does not express endogenous AIRE as
assessed by standard RT-PCR (unpublished data), for the
transfection. As expected, the full-length wild-type AIRE
induced activation of the reporter genes in mTEC (Fig. 3
A). The disease-causing mutant forms of PHD1 (C311Y
and P326Q), which lack E3 ligase activity, exhibited nor-
mal transcriptional activation. In contrast, a PHD2 mutant
(C434A) with normal E3 ligase activity showed dramati-
cally reduced transcriptional activation.
The distinct role of PHD1 and PHD2 in the function of
AIRE was further examined with the isolated PHD frag-
ments in the same Gal4-binding assays (Fig. 3 B). Neither
PHD1 alone nor PHD1 with a proline-rich region (PRR)
showed transcriptional activation. In contrast, PHD2 alone
was almost sufficient for the transcriptional activation, and
this activity was further pronounced when PRR was
added. These results further suggest a distinct role for each
PHD domain in the function of AIRE. PHD1 mediates E3
ligase activity, whereas PHD2 is essential for the transcrip-
tional activation.
Apparently normal transactivating properties in the ab-
sence of E3 ligase activity as a result of the disease-causing
Figure 2. Mutations in PHD1 affect E3 ligase
activity. (A) Schematic representation of the
PHD mutants used in the study. (B) Substitu-
tions of the first cysteines into alanines in
PHD1, or PHD1 and PHD2, but not in PHD2
alone, abolished E3 ligase activity (top). The
ubiquitylation reactions were subjected to
immunoblot  analysis with antibodies against
His6-tag (bottom). (C) Disease-causing muta-
tions of PHD1 (C311Y and P326Q) resulted in
loss of E3 ligase activity as assessed with in vitro
ubiquitylation assays. 
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mutations (Fig. 3 A) might be due to enforced recruitment
of AIRE to the target DNA in the Gal4-binding assay sys-
tem. It is possible to speculate that under physiological con-
ditions, E3 ligase activity is necessary for the organization
and/or modification of AIRE-interacting proteins in order
for AIRE to be located to the transcriptional complex. In
contrast, PHD2 might be an important platform required
for the recruitment of transcriptional coactivators and the
structural integrity of the PHD2 for this action might be
disrupted by the C434A mutation. However, it also remains
possible that AIRE is a multifunctional protein with E3 li-
gase activity and transcription-activating properties medi-
ated primarily through PHD1 and PHD2, respectively, and
that loss of E3 ligase activity may cause the disease indepen-
dently from the transcription-activating function of AIRE.
One characteristic features of AIRE is its subcellular lo-
calization. Immunocytochemical staining has revealed its
presence in the nucleus, appearing as a speckled pattern
known as a nuclear body (7, 8, 25). However, to a lesser
extent, AIRE also exists in the cytoplasm. To test whether
PHD domains are involved in the targeting of AIRE sub-
cellular localization, we have established mTEC lines stably
transfected with various PHD mutants using a retrovirus
expression system. Wild-type AIRE was observed in both
the cytoplasm and nucleus mainly as scattered fine dots, and
a similar distribution pattern of AIRE was observed in the
cells transfected with either the PHD1 mutant (C299A) or
PHD2 mutant (C434A; unpublished data). These results
indicate that targeting of AIRE to its defined subcellular lo-
calization does not depend on either E3 ligase activity or
transcription-activating properties, and further suggest that
loss of E3 ligase activity caused by the PHD1 mutations is
relevant to the development of the disease.
Despite the growing numbers of known PHD proteins
with E3 ligase activity, a defect of PHD E3 ligase had not
been suggested for the development of a human disease un-
til very recently. During the processing of this work, Meetei
et al. (26) reported a novel PHD-type E3 ligase with defec-
tive function in a patient with Fanconi anemia. Here we
have demonstrated that disease-causing mutations in the
PHD1 of AIRE result in the loss of its E3 ligase activity.
Because there are several naturally occurring mutations or
deletions in the PHDs implicated in human diseases, we
suspect that loss of E3 ligase activity might account for the
pathogenesis of some other diseases as well. These include
ATRX protein in 
 
 
 
-thalassemia and mental retardation
(27), AF10 in myeloid leukemias (28), and ING1 in squa-
mous cell carcinomas of the head and neck (29). The preva-
lence of disease-causing mutations in PHDs suggests that E3
ligase activity mediated through the PHDs could play an es-
sential role in the normal function of human cells (19), al-
though other aspects of PHD function need to be tested
(30). Identification of the specific target(s) of ubiquitylation
by AIRE is one of the most important tasks remaining in
order to clarify the molecular mechanisms by which AIRE
establishes and maintains self-tolerance.
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